Consider These MS Treatment Options

Name: Consider These MS Treatment Options
Uploaded: 2025-04-14T16:00:10+00:00
Duration: 33 s
Channel: Dr. Charles Mok
Description: Dr. Charles Mok discusses which MS patients benefit most from treatment. Those with gradual decline see the best results, while patients with total…

14 Apr 2025 · 1 min

Watch on YouTube

0:33

Dr. Charles Mok discusses which MS patients benefit most from treatment. Those with gradual decline see the best results, while patients with total axonal transection won't improve. He covers minocycline, testosterone, and stem cell therapy, noting costs and insurance coverage gaps.

Chapters

Some people might have advanced disease in their total axonal transection, which means their nerve cells are broken. They're not probably going to get any benefit, at least not from studies currently done. But the people that are kind of on their way sliding downhill have the most benefit. And we've been doing this for about 9 years with mixed success, but mostly favorable. That is something that is not covered by insurance. So if you have to pay out of your pocket, the minocycline is pretty inexpensive. Testosterone estol reasonably inexpensive. And stem cells are a little bit more on the expensive side. Something somebody can do for quality of life is certainly way cheaper than any drug used right now. If you do, that combination is far cheaper.